Proton pump inhibitors on pancreatic cancer risk and survival

Feb-17

AUTHORS : Dr Yu-Xiao Yang, MD, MSCE, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 423 Guardian Drive, 733 Blockley Hall, Philadelphia, Pennsylvania 19010, USA – Email: yangy@pennmedicine.upenn.edu / yangy@mail.med.upenn.edu – Profile: https://www.med.upenn.edu/apps/faculty/index.php/g275/p18504

JOURNAL : Cancer Epidemiology

REFERENCE: 46:80-84

DOI : 10.1016/j.canep.2016.12.006

Proton pump inhibitors on pancreatic cancer risk and survival

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease